Dr. Verma notes that Rybelsus 7mg, developed by Novo Nordisk India and priced at $18.00 for a blister card of 10 tablets, is commonly used to manage type 2 diabetes while also offering potential benefits for weight loss. Patients taking Rybelsus 7mg have reported gradual weight loss, with some individuals losing around 5-10% of their body weight over several months when combined with a proper diet and exercise plan. Common side effects include nausea or digestive discomfort, especially in the initial weeks. Dr. Verma emphasizes that while the weight loss effects are a helpful side benefit for many, Rybelsus is primarily designed for glucose management and should be taken under medical supervision for the best outcomes.